Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

References

• Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation, 2010. Available at: http://www.idf.org/idf-worldwide-definition-metabolic-syndrome. Accessed date: 13 October 2010.
   Google Scholar
• Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, . The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059–61.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation, 2010. Available at: http://www.idf.org/node/1405?unode=4A7F23CB-FA35-4471-BB06-0294AD33F2FC. Accessed date: 13 October 2010.
   Google Scholar
• Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, . Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628–47.
   PubMed Web of Science ®Google Scholar
• Kiess W, Blüher S, Kapellen T, Körner A. Metabolic syndrome in children and adolescents: prevalence, public health issue, and time for initiative. J Pediatr Gastroenterol Nutr. 2009;49:268–71.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Aradillas-García C, Simental-Mendia LE, Monreal-Escalante E, de la Cruz Mendoza E, Rodríguez-Moran M. Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents. J Pediatr. 2010;156:719–23, 723.e1.
   PubMed Web of Science ®Google Scholar
• Biro FM, Wien M. Childhood obesity and adult morbidities. Am J Clin Nutr. 2010;91:1499S–1505S.
   PubMed Web of Science ®Google Scholar
• Edmison JM, Kalhan SC, McCullough AJ. Obesity, hepatic metabolism and disease. Nestle Nutr Workshop Ser Pediatr Program. 2009;63:163–72; discussion 172–6, 259–68.
   PubMedGoogle Scholar
• Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr. 2009;21:529–35.
   PubMedGoogle Scholar
• Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr. 2009;155:469–74.
   PubMed Web of Science ®Google Scholar
• Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010;13: 397–402.
   PubMed Web of Science ®Google Scholar
• Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes. 2006;1:33–41.
   PubMed Web of Science ®Google Scholar
• Farrell GC. The liver and the waistline: Fifty years of growth. J Gastroenterol Hepatol. 2009;24 Suppl 3:S105–18.
   Google Scholar
• Nobili V, Cianfarani S, Agostoni C. Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle. J Hepatol. 2010;52:788–90.
   PubMedGoogle Scholar
• Nobili V, Alisi A, Panera N, Agostoni C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr Endocrinol Rev. 2008; 6:241–7.
   PubMedGoogle Scholar
• Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833–41.
   PubMed Web of Science ®Google Scholar
• Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, . Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Morán M, Salazar-Vázquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10–18 years. Diabetes Care. 2004;27: 2516–7.
   PubMedGoogle Scholar
• Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: Will the real definition please stand up. J Pediatr. 2008;152:160–4.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. The third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda: National Institutes of Health; 2001.
   Google Scholar
• Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157:821–7.
   PubMed Web of Science ®Google Scholar
• de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–7.
   PubMed Web of Science ®Google Scholar
• Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999–2000. Diabetes Care. 2004;27:2438–43.
   PubMed Web of Science ®Google Scholar
• Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001–2006. Arch Pediatr Adolesc Med. 2009;163:371–7.
   PubMed Web of Science ®Google Scholar
• Hoffman RP. Metabolic syndrome racial differences in adolescents. Curr Diabetes Rev. 2009;5:259–65.
   PubMedGoogle Scholar
• Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:195–203.
   PubMed Web of Science ®Google Scholar
• Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50:1282–93.
   PubMed Web of Science ®Google Scholar
• Pietrobattista A, Fruwirth R, Natali G, Monti L, Devito R, Nobili V. Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension. Pediatr Radiol. 2009;39:959–61.
   PubMedGoogle Scholar
• Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, Laffi G, . Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol. 2009;8:89–94.
   PubMedGoogle Scholar
• Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol. 2010;16:1560–6.
   PubMed Web of Science ®Google Scholar
• Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, . Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008;48:442–8.
   PubMed Web of Science ®Google Scholar
• Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271–81.
   PubMedGoogle Scholar
• Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol. 2009;8 Suppl 1:S44–50.
   Google Scholar
• Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, . NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006;44:458–65.
   PubMed Web of Science ®Google Scholar
• Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, . Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010;105:2093–102.
   PubMed Web of Science ®Google Scholar
• Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8(Suppl 1):S18–24.
   Google Scholar
• Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis. 2010; 42:320–30.
   PubMedGoogle Scholar
• Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, . A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006;29:113–22.
   PubMed Web of Science ®Google Scholar
• Jasik CB, Lustig RH. Adolescent obesity and puberty: the ‘perfect storm’. Ann N Y Acad Sci. 2008;1135:265–79.
   PubMedGoogle Scholar
• Joy T, Lahiry P, Pollex RL, Hegele RA. Genetics of metabolic syndrome. Curr Diab Rep. 2008;8:141–8.
   PubMed Web of Science ®Google Scholar
• Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006;1092:138–47.
   PubMed Web of Science ®Google Scholar
• Funahashi T, Matsuzawa Y. Metabolic syndrome: clinical concept and molecular basis. Ann Med. 2007;39:482–94.
   PubMed Web of Science ®Google Scholar
• Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10–14.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.
   PubMed Web of Science ®Google Scholar
• Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159 Suppl 1: S67–74.
   Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
   PubMed Web of Science ®Google Scholar
• Kennedy AJ, Ellacott KL, King VL, Hasty AH. Mouse models of the metabolic syndrome. Dis Model Mech. 2010;3: 156–66.
   PubMed Web of Science ®Google Scholar
• O'Sullivan TA, Lyons-Wall P, Bremner AP, Ambrosini GL, Huang RC, Beilin LJ, . Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: comparison of different metabolic syndrome definitions. Diabet Med. 2010;27:770–8.
   PubMed Web of Science ®Google Scholar
• Aeberli I, Spinas GA, Lehmann R, l'Allemand D, Molinari L, Zimmermann MB. Diet determines features of the metabolic syndrome in 6- to 14-year-old children. Int J Vitam Nutr Res. 2009;79:14–23.
   PubMedGoogle Scholar
• Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc. 2008;108:276–86.
   PubMedGoogle Scholar
• Sookoian S, Pirola CJ. Metabolic syndrome: From the genetics to the pathophysiology. Curr Hypertens Rep. 2010 Oct 19 (Epub ahead of print).
   Google Scholar
• Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care. 2004;27:775–80.
   PubMedGoogle Scholar
• Santoro N, Cirillo G, Amato A, Luongo C, Raimondo P, D'Aniello A, . Insulin gene variable number of tandem repeats (Ins Vntr) genotype and metabolic syndrome in childhood obesity. J Clin Endocrinol Metab. 2006;91: 4641–4.
   PubMedGoogle Scholar
• Chu NF, Chang JB, Shieh SM. Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children. Obes Res. 2003;11:532–40.
   PubMedGoogle Scholar
• Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New predictors of the metabolic syndrome in children—role of adipocytokines. Pediatr Res. 2007;61:640–5.
   PubMed Web of Science ®Google Scholar
• Calcaterra V, De Amici M, Klersy C, Torre C, Brizzi V, Scaglia F, . Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed. 2009;80:117–23.
   PubMedGoogle Scholar
• Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.
   PubMed Web of Science ®Google Scholar
• Túri S, Friedman A, Bereczki C, Papp F, Kovàcs J, Karg E, . Oxidative stress in juvenile essential hypertension. J Hypertens. 2003;21:145–52.
   PubMed Web of Science ®Google Scholar
• Sinaiko A, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, . Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation. 2005;111:1985–91.
   PubMed Web of Science ®Google Scholar
• Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr. 2006;1:248–52.
   PubMedGoogle Scholar
• McCall A, Raj R. Exercise for prevention of obesity and diabetes in children and adolescents. Clin Sports Med. 2009;28:393–421.
   PubMed Web of Science ®Google Scholar
• de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48 Suppl 1: S104–12.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 2008;19:371–9.
   PubMed Web of Science ®Google Scholar
• Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009;51:212–23.
   PubMed Web of Science ®Google Scholar
• Cheung O, Sanyal AJ. Abnormalities of lipid metabolism in non-alcoholic fatty liver disease. Semin Liver Dis. 2008;28:351–9.
   PubMed Web of Science ®Google Scholar
• Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2009;19:291–302.
   PubMed Web of Science ®Google Scholar
• Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13:545–63.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48:1–26.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol. 2009;44:6–14.
   PubMed Web of Science ®Google Scholar
• Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond). 2008;32:381–7.
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlations of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500–5.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med. 2009;87:679–95.
   PubMed Web of Science ®Google Scholar
• Duvnjak M, Leroti I, Barsi N, Tomasi V, Virovi Juki L, Velagi V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 2007; 13:4539–50.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774–88.
   PubMed Web of Science ®Google Scholar
• Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol. 2008;43:811–22.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9:299–314.
   PubMedGoogle Scholar
• Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr. 2005;147:835–8.
   PubMedGoogle Scholar
• Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, . Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol. 2006;155:735–43.
   PubMed Web of Science ®Google Scholar
• Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645–9.
   PubMed Web of Science ®Google Scholar
• Wilfred de Alwis NM, Day CP. Genes and nonalcoholic fatty liver disease. Curr Diab Rep. 2008;8:156–63.
   PubMedGoogle Scholar
• Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–93.
   PubMed Web of Science ®Google Scholar
• Day CP. Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig Dis. 2010;28:255–60.
   PubMed Web of Science ®Google Scholar
• Duvnjak M, Barsi N, Tomasi V, Leroti I. Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression. World J Gastroenterol. 2009;15:6023–7.
   PubMedGoogle Scholar
• Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, Pirola CJ. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens. 2005;18:1271–5.
   PubMed Web of Science ®Google Scholar
• Sookoian SC, González C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res. 2005;13:2122–31.
   PubMedGoogle Scholar
• Zák A, Jáchymová M, Tvrzická E, Vecka M, Duffková L, Zeman M, . The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. J Nutr Biochem. 2008;19:634–41.
   PubMed Web of Science ®Google Scholar
• Vasseur F, Meyre D, Froguel P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med. 2006;8:1–12.
   Google Scholar
• Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, Helal O, . Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr. 2010;91:794–801.
   PubMedGoogle Scholar
• Sookoian S, García SI, Porto PI, Dieuzeide G, González CD, Pirola CJ. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol. 2005;35:373–80.
   PubMed Web of Science ®Google Scholar
• Vimaleswaran KS, Radha V, Deepa R, Mohan V. Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians. Metab Syndr Relat Disord. 2007;5:153–62.
   PubMedGoogle Scholar
• Robitaille J, Brouillette C, Houde A, Lemieux S, Pérusse L, Tchernof A, . Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet. 2004;49:482–9.
   PubMedGoogle Scholar
• Phillips CM, Goumidi L, Bertrais S, Field MR, Ordovas JM, Cupples LA, . Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr. 2010;140:238–44.
   PubMed Web of Science ®Google Scholar
• Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I. Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res. 2006;55:483–90.
   PubMedGoogle Scholar
• Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, . Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010;25:772–7.
   PubMedGoogle Scholar
• Chien KL, Hsu HC, Chen YC, Su TC, Lee YT, Chen MF. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis. Transl Res. 2009;154:133–41.
   PubMedGoogle Scholar
• Johansson LE, Johansson LM, Danielsson P, Norgren S, Johansson S, Marcus C, . Genetic variance in the adiponutrin gene family and childhood obesity. PLoS One. 2009;4:e5327.
   Google Scholar
• Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, . Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–5.
   PubMed Web of Science ®Google Scholar
• Hoekstra M, Li Z, Kruijt JK, Eck MV, Berkel TJ, Kuiper J. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol. 2010;52:244–51.
   PubMed Web of Science ®Google Scholar
• Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. Characterization of the human patatin-like phospholipase family. J Lipid Res. 2006;47:1940–9.
   PubMed Web of Science ®Google Scholar
• Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, . Homozygosity for the PNPLA3 / adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1209–17.
   PubMed Web of Science ®Google Scholar
• Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, . I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology. 2010;52:1274–80.
   PubMed Web of Science ®Google Scholar
• Hales C, Barker D, Clark P, Cox L, Fall C, Osmond C, . Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019–22.
   PubMed Web of Science ®Google Scholar
• Geremia C, Cianfarani S. Insulin sensitivity in children born small for gestational age (SGA). Rev Diabet Stud. 2004;1: 58–65.
   PubMedGoogle Scholar
• Lévy-Marchal C, Czernichow P. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies? Horm Res. 2006;65 Suppl 3:123–30.
   PubMedGoogle Scholar
• Fowden A, Giussani D, Forhead A. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006;21:29–37.
   PubMed Web of Science ®Google Scholar
• Lucas A. Programming by early nutrition in man. Ciba Found Symp. 1991;156:38–50.
   PubMedGoogle Scholar
• Godfrey K, Lillycrop K, Burdge G, Gluckman P, Hanson M. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res. 2007;61:5R–10R.
   PubMed Web of Science ®Google Scholar
• Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.
   PubMed Web of Science ®Google Scholar
• Nair L, Nair MK, Chacko DS. Markers of fetal onset adult diseases. Indian Pediatr. 2009;46:48–54.
   Google Scholar
• Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32:213–8.
   PubMed Web of Science ®Google Scholar
• Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birth-weight with diabetes and vascular disease. Lancet. 1999; 353:1789–92.
   PubMed Web of Science ®Google Scholar
• Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19: 268–70.
   PubMed Web of Science ®Google Scholar
• Gluckman P, Hanson M, Buklijas T, Low F, Beedle A. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol. 2009;5:401–8.
   PubMed Web of Science ®Google Scholar
• Goyal R, Goyal D, Leitzke A, Gheorghe C, Longo L. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17:227–38.
   PubMed Web of Science ®Google Scholar
• Pinney S, Simmons R. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab. 2010;21:223–9.
   PubMed Web of Science ®Google Scholar
• Heijmans B, Tobi E, Stein A, Putter H, Blauw G, Susser E, . Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008;105:17046–9.
   PubMed Web of Science ®Google Scholar
• Eriksson J, Osmond C, Kajantie E, Forsén T, Barker D. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006;49:2853–8.
   PubMed Web of Science ®Google Scholar
• Barker D, Hales C, Fall C, Osmond C, Phipps K, Clark P. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62–7.
   PubMed Web of Science ®Google Scholar
• Eriksson J, Forsén T, Tuomilehto J, Jaddoe V, Osmond C, Barker D. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia. 2002;45:342–8.
   PubMed Web of Science ®Google Scholar
• Claris O, Beltrand J, Levy-Marchal C. Consequences of intrauterine growth and early neonatal catch-up growth. Semin Perinatol. 2010;34:207–10.
   PubMed Web of Science ®Google Scholar
• Fagerberg B, Bondjers L, Nilsson P. Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. J Intern Med. 2004;256:254–9.
   PubMed Web of Science ®Google Scholar
• Bhargava S, Sachdev H, Fall C, Osmond C, Lakshmy R, Barker D, . Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004;350:865–75.
   PubMed Web of Science ®Google Scholar
• Ravelli G, Stein Z, Susser M. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976;295:349–53.
   PubMed Web of Science ®Google Scholar
• Ravelli A, van der Meulen J, Michels R, Osmond C, Barker D, Hales C, . Glucose tolerance in adults after prenatal exposure to famine. Lancet. 1998;351:173–7.
   PubMed Web of Science ®Google Scholar
• Ravelli A, van Der Meulen J, Osmond C, Barker D, Bleker O. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr. 1999;70:811–6.
   PubMed Web of Science ®Google Scholar
• Roseboom T, van der Meulen J, Ravelli A, van Montfrans G, Osmond C, Barker D, . Blood pressure in adults after prenatal exposure to famine. J Hypertens. 1999;17:325–30.
   PubMedGoogle Scholar
• Gluckman P, Hanson M. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes (Lond). 2008;32 Suppl 7:S62–71.
   PubMed Web of Science ®Google Scholar
• Kirk S, Samuelsson A, Argenton M, Dhonye H, Kalamatianos T, Poston L, . Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS One. 2009;4:e5870.
   PubMed Web of Science ®Google Scholar
• Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ. 2005;331:929.
   PubMed Web of Science ®Google Scholar
• Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, . Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007;30:2638–40.
   PubMed Web of Science ®Google Scholar
• Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, . A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child. 2009;94:801–5.
   PubMed Web of Science ®Google Scholar
• Koletzko B, von Kries R, Closa R, Monasterolo RC, Escribano J, Subias JE, . Can infant feeding choices modulate later obesity risk? Am J Clin Nutr. 2009;89:1502S–8S.
   PubMed Web of Science ®Google Scholar
• Schack-Nielsen L, Sorensen TI, Mortensen EL, Michaelsen KF. Late introduction of complementary feeding, rather than duration of breastfeeding, may protect against adult overweight. Am J Clin Nutr. 2010;91:619–27.
   PubMed Web of Science ®Google Scholar
• Bartok CJ, Ventura AK. Mechanisms underlying the association between breastfeeding and obesity. Int J Pediatr Obes. 2009;4:196–204.
   PubMed Web of Science ®Google Scholar
• Brambilla P, Lissau I, Flodmark CE, Moreno LA, Widhalm K, Wabitsch M, . Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes. 2007;31:591–600.
   PubMed Web of Science ®Google Scholar